Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
B7535 Eeyarestatin ITarget: ERADSummary: inhibitor of endoplasmic reticulum-associated degradation (ERAD) and protein translocation -
B7637 SMER 28Summary: Positive regulator of autophagy -
B7727 NSC 624206Summary: Ubiquitin-activating enzyme (E1) inhibitor -
A8198 P 22077Summary: USP7/(DUB)USP47 inhibitor -
A3023 P0050911 CitationTarget: Ubiquitin-specific proteasesSummary: Ubiquitin-specific protease 7 (USP7) inhibitor -
A4003 LDN 57444Target: UCHSummary: UCH-L1 inhibitor,reversible competitve -
A4004 NSC 632839 hydrochlorideSummary: Isopeptidases inhibitor -
A4007 MLN97086 CitationTarget: ProteasomeSummary: Proteasome inhibitor -
A2601 Aclacinomycin ATarget: TopoisomerasesSummary: Topoisomerase I and II inhibitor -
A2604 CelastrolTarget: ProteasomeSummary: Antioxidant, anti-inflammatory and immunosuppressive agent

